Sex Is a major determinant of neuronal dysfunction in neurofibromatosis type 1.
about
RASopathies: unraveling mechanisms with animal modelsEliminating barriers to personalized medicine: learning from neurofibromatosis type 1Differential diagnoses of overgrowth syndromes: the most important clinical and radiological disease manifestationsA RASopathy gene commonly mutated in cancer: the neurofibromatosis type 1 tumour suppressorThe cyclic AMP pathway is a sex-specific modifier of glioma risk in type I neurofibromatosis patients.The impact of coexisting genetic mutations on murine optic glioma biology.Akt- or MEK-mediated mTOR inhibition suppresses Nf1 optic glioma growth.Anaplastic Lymphoma Kinase Acts in the Drosophila Mushroom Body to Negatively Regulate Sleep.Optic pathway gliomas in neurofibromatosis-1: controversies and recommendations.Pediatric gliomas as neurodevelopmental disordersSex bias in autism spectrum disorder in neurofibromatosis type 1NF1 germline mutation differentially dictates optic glioma formation and growth in neurofibromatosis-1.Estrogen activation of microglia underlies the sexually dimorphic differences in Nf1 optic glioma-induced retinal pathology.In vivo severity ranking of Ras pathway mutations associated with developmental disorders.Cognitive and behavioral problems in children with neurofibromatosis type 1: challenges and future directions.Improving outcomes for neurofibromatosis 1-associated brain tumors.Characterization of early communicative behavior in mouse models of neurofibromatosis type 1.Attention deficit hyperactivity disorder (ADHD) in phenotypically similar neurogenetic conditions: Turner syndrome and the RASopathiesCNS Tumors in Neurofibromatosis.Disease Burden and Symptom Structure of Autism in Neurofibromatosis Type 1: A Study of the International NF1-ASD Consortium Team (INFACT).Deficit in phonological processes: a characteristic of the neuropsychological profile of children with NF1.Exploring the genetic basis for clinical variation in neurofibromatosis type 1.Neurofibromatosis Type 1-Associated MPNST State of the Science: Outlining a Research Agenda for the Future.Natural history of optic pathway gliomas in a cohort of unselected patients affected by Neurofibromatosis 1.Optic Pathway Gliomas in Neurofibromatosis Type 1.Neurofibromatosis type 1 and optic pathway glioma: Molecular interplay and therapeutic insights.Defining the temporal course of murine neurofibromatosis-1 optic gliomagenesis reveals a therapeutic window to attenuate retinal dysfunction.The effect of parental age on NF1 patients in Turkey.Reply: To PMID 24375753.Gender as a disease modifier in neurofibromatosis type 1 optic pathway glioma.Contributions of inflammation and tumor microenvironment to neurofibroma tumorigenesis.The investigation for potential modifier genes in patients with neurofibromatosis type 1 based on next-generation sequencing.Serial MRIs provide novel insight into natural history of optic pathway gliomas in patients with neurofibromatosis 1.Attention and Executive Disorders in Neurofibromatosis 1: Comparison Between NF1 With ADHD Symptomatology (NF1 + ADHD) and ADHD Per Se
P2860
Q26800379-FD3EBA37-3524-4132-BC71-FF56BA8AAFE9Q26828988-5E77CE33-50C7-4F97-AB92-5319401719D5Q27002915-980FA4D5-E516-467A-B8CE-162472169D2DQ27003534-A5C70E92-92A6-487E-9962-3B8D29CFF8CBQ34859935-3409EB6B-9761-4103-90BC-AE9DAE9270EAQ35788566-DA45287A-9883-4EAF-B2A1-8A3E4D434961Q35788976-897AC961-68DC-4D2F-99D6-42935EFEAF92Q35832009-14C55455-5094-47D3-9E2A-303460FF8399Q36771546-8F2208FA-D24F-4B04-B328-BCB81D1571E5Q36803476-F7E73661-1238-4F54-9FD5-CA99672EFB23Q37167036-45210A50-8B7D-480D-A494-E4B114AB235CQ37178573-879E2068-825B-4353-B52F-37F0B2FE0F94Q37549711-ECEBFF05-3E9C-4127-8E81-0F5BF53C1A79Q37599060-221E3373-5DAA-4433-BD56-7D2772833080Q38243763-FB8C6A35-2D76-4F70-B6B0-2F58EEC3A6C1Q38344456-08B9949A-6FF0-4292-BBA2-0AD4C7A7F287Q38607455-0F1F3EB0-2025-45DE-BA7C-965226132908Q38659714-1A5B711C-76EF-44E8-AF69-45D112C5B558Q38713914-FA1E18EA-F58B-4521-A73B-31601DFE34B7Q38808993-D81CD852-02D7-4EC9-AF80-547326998AA9Q40250842-5042C083-6F49-4ED2-83CD-C169AD3C1A9BQ41172460-09A6293B-9736-478F-AB73-06953DDAA900Q45951553-8F7A78DA-6CA1-43E1-9213-CD26312936AEQ47743242-E6E989C4-D5FB-43A2-905F-5BC11D03E2CDQ47779215-1BA478D2-8D67-4504-831B-B796AE72A06BQ47887929-060ED1F3-33AD-4F38-AE05-C6175D40A7ABQ48376754-2ADA561E-0504-479A-85C9-5266EEAFBA25Q49977343-F74A44B8-E8C5-4254-87BA-6BDEF900F711Q50668997-D14A4E25-6142-4AF4-87D9-01306F6DEEBCQ50669853-38A34443-211A-4755-BC5D-9F14CC3DAC48Q52622505-C95001D7-C3D1-4406-963E-19932CF9D3E7Q52674888-24A08001-DAEC-44FC-BF60-0175B185271BQ55253583-248C3519-DC6D-4EBE-B3FE-A1E468B5A2CFQ57581441-EABA3544-B808-4C45-8897-58A279275514
P2860
Sex Is a major determinant of neuronal dysfunction in neurofibromatosis type 1.
description
2014 nî lūn-bûn
@nan
2014 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Sex Is a major determinant of neuronal dysfunction in neurofibromatosis type 1.
@ast
Sex Is a major determinant of neuronal dysfunction in neurofibromatosis type 1.
@en
Sex Is a major determinant of neuronal dysfunction in neurofibromatosis type 1.
@nl
type
label
Sex Is a major determinant of neuronal dysfunction in neurofibromatosis type 1.
@ast
Sex Is a major determinant of neuronal dysfunction in neurofibromatosis type 1.
@en
Sex Is a major determinant of neuronal dysfunction in neurofibromatosis type 1.
@nl
prefLabel
Sex Is a major determinant of neuronal dysfunction in neurofibromatosis type 1.
@ast
Sex Is a major determinant of neuronal dysfunction in neurofibromatosis type 1.
@en
Sex Is a major determinant of neuronal dysfunction in neurofibromatosis type 1.
@nl
P2093
P2860
P356
P1433
P1476
Sex Is a major determinant of neuronal dysfunction in neurofibromatosis type 1.
@en
P2093
David F Wozniak
Jacquelyn A Brown
Joshua B Rubin
Kelly A Diggs-Andrews
Scott M Gianino
P2860
P304
P356
10.1002/ANA.24093
P577
2014-02-06T00:00:00Z